HCW Biologics Gross Profit Growth & History (HCWB)
HCW Biologics's gross profit was $10,846 for fiscal 2025.
View full HCW Biologics company overviewHCW Biologics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $10,846 | −$948,557 | −98.87% |
| 2024 | 2024-12-31 | $959,403 | $399,043 | +71.21% |
| 2023 | 2023-12-31 | $560,360 | −$2.0M | −78.33% |
| 2022 | 2022-12-31 | $2.6M | $2.6M | — |
| 2021 | 2021-12-31 | $0 | — | — |
HCW Biologics quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$93,887 | −$95,197 | — |
| Q1 2026 | 2026-03-31 | $6.5M | $6.5M | +644710.46% |
| Q4 2025 | 2025-12-31 | $5,402 | −$73,558 | −93.16% |
| Q3 2025 | 2025-09-30 | $3,121 | −$82,164 | −96.34% |
| Q2 2025 | 2025-06-30 | $1,310 | −$179,101 | −99.27% |
| Q1 2025 | 2025-03-31 | $1,013 | −$613,734 | −99.84% |
| Q4 2024 | 2024-12-31 | $78,960 | −$173,685 | −68.75% |
| Q3 2024 | 2024-09-30 | $85,285 | −$89,492 | −51.20% |
| Q2 2024 | 2024-06-30 | $180,411 | $60,006 | +49.84% |
| Q1 2024 | 2024-03-31 | $614,747 | $602,214 | +4805.03% |
| Q4 2023 | 2023-12-31 | $252,645 | −$15,659 | −5.84% |
| Q3 2023 | 2023-09-30 | $174,777 | −$187,028 | −51.69% |
| Q2 2023 | 2023-06-30 | $120,405 | −$46,395 | −27.81% |
| Q1 2023 | 2023-03-31 | $12,533 | −$1.8M | −99.30% |
| Q4 2022 | 2022-12-31 | $268,304 | $268,304 | — |
| Q3 2022 | 2022-09-30 | $361,805 | $361,805 | — |
| Q2 2022 | 2022-06-30 | $166,800 | $166,800 | — |
| Q1 2022 | 2022-03-31 | $1.8M | $1.8M | — |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $0 | — | — |
HCW Biologics gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, HCW Biologics's gross profit increased from $0 to $10,846, a change of $10,846. The latest reported quarter, Q2 2026, shows −$93,887.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCW Biologics source filings ↗